Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 2 |
2019 | 5 |
2020 | 3 |
2023 | 0 |
Search Results
7
results
Results by year
Page 1
Predictors of treatment outcome in patients with paediatric onset multiple sclerosis.
Mult Scler. 2020 Jul;26(8):964-975. doi: 10.1177/1352458519846100. Epub 2019 May 13.
Mult Scler. 2020.
PMID: 31081451
Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study.
Buron MD, Chalmer TA, Sellebjerg F, Barzinji I, Danny B, Christensen JR, Christensen MK, Hansen V, Illes Z, Jensen HB, Kant M, Papp V, Petersen T, Prakash S, Rasmussen PV, Schäfer J, Theódórsdóttir Á, Weglewski A, Sorensen PS, Magyari M.
Buron MD, et al. Among authors: chalmer ta.
Neurology. 2020 Aug 25;95(8):e1041-e1051. doi: 10.1212/WNL.0000000000010135. Epub 2020 Jul 7.
Neurology. 2020.
PMID: 32636328
Item in Clipboard
Comparative effectiveness of teriflunomide and dimethyl fumarate: A nationwide cohort study.
Buron MD, Chalmer TA, Sellebjerg F, Frederiksen J, Góra MK, Illes Z, Kant M, Mezei Z, Petersen T, Rasmussen PV, Roshanisefat H, Hassanpour-Kalam-Roudy H, Sejbæk T, Tsakiri A, Weglewski A, Sorensen PS, Magyari M.
Buron MD, et al. Among authors: chalmer ta.
Neurology. 2019 Apr 16;92(16):e1811-e1820. doi: 10.1212/WNL.0000000000007314. Epub 2019 Mar 15.
Neurology. 2019.
PMID: 30877188
Free PMC article.
Item in Clipboard
Effectiveness of glatiramer acetate in neutralizing antibody-positive patients previously treated with interferon-β.
Buron MD, Magyari M, Chalmer TA, Sørensen PS, Sellebjerg F.
Buron MD, et al. Among authors: chalmer ta.
Mult Scler Relat Disord. 2019 Dec 16;39:101894. doi: 10.1016/j.msard.2019.101894. Online ahead of print.
Mult Scler Relat Disord. 2019.
PMID: 31884382
Item in Clipboard
Early versus later treatment start in multiple sclerosis: a register-based cohort study.
Chalmer TA, Baggesen LM, Nørgaard M, Koch-Henriksen N, Magyari M, Sorensen PS; Danish Multiple Sclerosis Group.
Chalmer TA, et al.
Eur J Neurol. 2018 Oct;25(10):1262-e110. doi: 10.1111/ene.13692. Epub 2018 Jul 9.
Eur J Neurol. 2018.
PMID: 29847005
Item in Clipboard
Treatment escalation leads to fewer relapses compared with switching to another moderately effective therapy.
Chalmer TA, Kalincik T, Laursen B, Sorensen PS, Magyari M; Members of Danish Multiple Sclerosis Group.
Chalmer TA, et al.
J Neurol. 2019 Feb;266(2):306-315. doi: 10.1007/s00415-018-9126-y. Epub 2018 Dec 4.
J Neurol. 2019.
PMID: 30515628
Item in Clipboard
Clinically stable disease is associated with a lower risk of both income loss and disability pension for patients with multiple sclerosis.
Chalmer TA, Buron M, Illes Z, Papp V, Theodorsdottir A, Schäfer J, Hansen V, Asgari N, Skejø PB, Jensen HB, Sørensen PS, Magyari M.
Chalmer TA, et al.
J Neurol Neurosurg Psychiatry. 2020 Jan;91(1):67-74. doi: 10.1136/jnnp-2019-321523. Epub 2019 Nov 14.
J Neurol Neurosurg Psychiatry. 2020.
PMID: 31727727
Item in Clipboard
Cite
Cite